John Thomas, MD
Internal Medicine · Spring, TXNPI 1013039841
Payments from drug & device makers
Across 148 payments — averaging $673.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$90K
- AbbVie$2K
- Medtronic$2K
- Polarityte, Inc.$1K
- Reapplix Inc.$1K
- Vaporox, Inc.$577
- plus $3K from 21 others
What the payments were for
- Consulting fees$10,50011%
- Speaking & faculty fees$60,51361%
- Travel & lodging$18,99519%
- Food & beverage$6,7117%
- Education$1,8002%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 37 | $89,968 |
| AbbVie | 9 | $2,060 |
| Medtronic(2 entities) | 22 | $1,754 |
| Polarityte, Inc. | 4 | $1,263 |
| Reapplix Inc. | 2 | $1,257 |
| Vaporox, Inc. | 8 | $577 |
| Smith+Nephew | 20 | $572 |
| KCI USA, Inc. | 4 | $358 |
| Convatec Inc. | 9 | $347 |
| Johnson & Johnson(2 entities) | 3 | $251 |
| Cardiovascular Systems Inc. | 3 | $217 |
| W. L. Gore & Associates, Inc. | 2 | $198 |
| Next Science LLC | 1 | $159 |
| Medline Industries LP | 2 | $145 |
| Hartmann USA, Inc. | 5 | $117 |
| Reprise Biomedical, Inc. | 2 | $107 |
| Abbott | 1 | $102 |
| Amniox Medical, Inc. | 2 | $43 |
| Argon Medical Devices, Inc. | 3 | $38 |
| Boston Scientific | 1 | $34 |
| Cashflow Solutions, LLC | 2 | $30 |
| Legend Biotech USA Inc. | 1 | $28 |
| Stryker | 1 | $20 |
| Triad Life Sciences Inc. | 1 | $17 |
| Hydrofera LLC | 1 | $17 |
| AstraZeneca | 1 | $15 |
| MDD US Operations, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis Omega3 SurgiClose$186,911
- Kerecis Omega3 Marigen$179,518
- Kerecis Omega3 GraftGuide$60,095
- Kerecis SurgiClose$17,800
- Kerecis GraftGuide$4,450
- ALLODERM$1,744
- SkinTE$1,263
- VenaSeal$814
- ABTHERA$225
- Diamondback Peripheral$215
- GORE VIABAHN VBX Balloon Expandable Endo$174
- SurgX$159
- Xperience$159
- BlastX$159
- COREVALVE EVOLUT R$148
- Resolute$124
- GRAFIX PL$118
- Hyalomatrix Wound Device$114
- PluroGel Burn & Wound Dressings$114
- XARELTO$108
How this compares
$99,707 in reported general payments places this provider in the 95th percentile of 7,675 internal medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 32 | $211 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Spring
- Jan BurgerHouston$47.3M
- Nitin JainHouston$33.2M
- Muhammad IrfanTomball$30.6M
- Aung NaingHouston$30.6M
- Robert BassSan Antonio$25.6M
- Preetesh JainHouston$19.5M
- Paolo StratiHouston$19.2M
- Hernan SalazarSan Antonio$18.5M
- Nicholas ShortHouston$17.6M
- Salma SaigerMesquite$16.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.